Cerebral Infarctions Recruiting Phase 2 Trials for Fluoxetine (DB00472)

Also known as: Cerebral Infarct / Cerebral Infarction / Stroke NOS / Infarct cerebral

IndicationStatusPhase
DBCOND0047013 (Cerebral Infarctions)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03448159Fluoxetine Opens Window to Improve Motor Recovery After StrokeTreatment